Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 8, 2013, Pages

  Lataro, Renata M ^a   Silva, Carlos A A ^a   Fazan Jr , Rubens ^a   Rossi, Marcos A ^a   Prado, Cibele M ^a   Godinho, Rosely O ^b   Salgado, Helio C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anticholinesterase agent; Autonomic imbalance; Cardiac function; Cardiac remodeling; Vagal stimulation

Indexed keywords

METHYLATROPINE; PROPRANOLOL; PYRIDOSTIGMINE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DRUG EFFECT; FIBROSING ALVEOLITIS; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HEART RHYTHM; HEART STROKE VOLUME; HEART VENTRICLE FAILURE; HEMODYNAMIC MONITORING; MALE; MUSCLE CELL; NONHUMAN; PARASYMPATHETIC TONE; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE; VAGUS TONE;

ANTICHOLINESTERASE AGENT; AUTONOMIC IMBALANCE; CARDIAC FUNCTION; CARDIAC REMODELING; VAGAL STIMULATION;

ANIMALS; CHOLINESTERASE INHIBITORS; HEART; HEART FAILURE; HEART RATE; MALE; PARASYMPATHETIC NERVOUS SYSTEM; PYRIDOSTIGMINE BROMIDE; RATS; RATS, WISTAR; VAGUS NERVE; VENTRICULAR DYSFUNCTION;

EID: 84885585703     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00102.2013     Document Type: Article

References (75)

1. Alves-Amaral G, Oliveira MP, Lopes ALA, Chiavegatti T, Godinho RO. Genderrelated differences in circadian rhythm of rat plasma acetyland butyrylcholinesterase: effects of sex hormone withdrawal. Chem Biol Interact 186: 9-15, 2010.
2. Androne AS, Hryniewicz K, Goldsmith R, Arwady A, Katz SD. Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart 89: 854-858, 2003.
3. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial response to infarction in the rat: morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Pathol 118: 484-492, 1985.
4. Azevedo ER, Parker JD. Parasympathetic control of cardiac sympathetic activity. Normal ventricular function versus congestive heart failure. Circulation 100: 274-279, 1999.
5. Behling A, Moraes RS, Rohde LE, Ferlin EL, Nóbrega AC, Ribeiro JP. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am Heart J 146: 494-500, 2003.
6. Bibevski S, Dunlap ME. Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev 16: 129-35, 2011.
7. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympa-thetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 18: 464-472, 1991.
8. Boudoulas H, Rittgers SE, Lewis RP, Leier CV, Weissler AM. Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation 60: 164-169, 1979.
9. Braunwald E, Collucci WS, Crossman W. Clinical aspects of heart failure: high-output heart failure; pulmonary edema. In: Heart Disease: A Textbook of Cardiovascular Medicine, edited by Braunwald E. Philadelphia, PA: Saunders, 1997.
10. Brown MD, Davies MK, Hudlická O. Angiogenesis in ischemic and hypertrophic hearts induced by long-term bradycardia. Angiogenesis 8: 253-262, 2005.
11. Brown MD, Hudlická O. Protective effects of long-term bradycardial pacing against catecholamine-induced myocardial damage in rabbit hearts. Circ Res 62: 965-974, 1988.
12. Chapleau MW, Sabharwal R. Methods of assessing vagus nerve activity and reflexes. Heart Fail Rev 16: 109-127, 2011.
13. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823, 1984.
14. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 98: 1329-1334, 1998.
15. Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100: 2210-2212, 1999.
16. Da Pureza DY, Jorge L, Sanches IC, Irigoyen MC, De Souza RR, De Angelis K. Acute exercise adjustments of cardiovascular autonomic control in diabetic rats. Muscle Nerve 46: 96-101, 2012.
17. De Ferrari GM, Schwartz PJ. Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. Heart Fail Rev 16: 195-203, 2011.
18. De Pontes PV, Bastos BG, Romeo Filho LJ, Mesquita ET, Nóbrega AC. Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects. Arq Bras Cardiol 72: 297-306, 1999.
19. Desai MY, Watanabe MA, Laddu AA, Hauptman PJ. Pharmacologic modulation of parasympathetic activity in heart failure. Heart Fail Rev 16: 179-193, 2011.
20. Dewland TA, Androne AS, Lee FA, Lampert RJ, Katz SD. Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes. Am J Physiol Heart Circ Physiol 293: H86-H92, 2007.
21. Dias DP, Oliveira M, Salgado HC, Fazan R Jr. Ovariectomy does not affect the cardiac sympathovagal balance of female SHR but estradiol does. Braz J Med Biol Res 43: 969-75, 2010.
22. Eckberg DL, Drabinsk M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285: 877-883, 1971.
23. El-Armouche A, Eschenhagen T. fj-Adrenergic stimulation and myocardial function in the failing heart. Heart Fail Rev 14: 225-241, 2009.
24. Ellman GL, Courtney DK, Andres V Jr, Featherstone RM. A new and rapid colorimetric assay determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95, 1961.
25. Feldman MD, Erikson JM, Mao Y, Korcarz CE, Lang RM, Freeman GL. Validation of a mouse conductance system to determine LV volume: comparison to echocardiography and crystals. Am J Physiol Heart Circ Physiol 279: H1698-H1707, 2000.
26. Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Circulation 118: 818-827, 2008.
27. Francis J, Weiss RM, Wei SG, Johnson AK, Felder RB. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regul Integr Comp Physiol 281: R1734-R1745, 2001.
28. Grodner AS, Lahrtz ASH, Pool GPE, Braunwald E. Neurotransmitter control of sinoatrial pacemaker frequency in isolated rat atria and in intact rabbits. Circ Res 27: 867-873, 1970.
29. Heba G, Krzeminski T, Porc M, Grzyb J, Ratajska A, Dembinska-Kiec A. The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats. J Vasc Res 38: 288-300, 2001.
30. Ishise G, Asanoi G, Ishizaka S, Joho S, Kameyama T, Umeno K, Inoue H. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol 84: 1234-1241, 1998.
31. Jegger D, Jeanrenaud X, Nasratullah M, Chassot PG, Mallik A, Tevaearai H, von Segesser LK, Segers P, Stergiopulos N. Noninvasive Doppler-derived myocardial performance index in rats with myocardial infarction: validation and correlation by conductance catheter. Am J Physiol Heart Circ Physiol 290: H1540-H1548, 2006.
32. Kalkman EA, Van Haren P, Saxena PR, Schoemaker RG. Regionally different vascular response to vasoactive substances in the remodeled infarcted rat heart: aberrant vasculature in the infarct scar. J Mol Cell Cardiol 29: 1487-1497, 1997.
33. Karam R, Healy BP, Wicker P. Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. Circulation 81: 238-246, 1990.
34. Kirchheim HR, Just A, Ehmke H. Physiology and pathophysiology of baroreceptor function and neuro-hormonal abnormalities in heart failure. Basic Res Cardiol 93: 1-22, 1998.
35. Lei L, Zhou R, Zheng W, Christensen LP, Weiss RM, Tomanek RJ. Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart. Circulation 110: 796-802, 2004.
36. Levy MN, Blattberg B. Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 38: 81-85, 1976.
37. Levy MN, Zieske H. Autonomic control of cardiac pacemaker activity and atrioventricular transmission. J Appl Physiol 27: 465-470, 1969.
38. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res 29: 437-445, 1971.
39. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol Heart Circ Physiol 270: H1803-H1811, 1996.
40. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109: 120-124, 2004.
41. Manabe N, Foldes FF, Torocsik A, Nagashima H, Goldiner PL, Vizi ES. Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetylcholine and noradrenaline release. J Auton Nerv Syst 32: 233-242, 1991.
42. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88: 136-145, 1993.
43. Mircoli L, Fedele L, Benetti M, Bolla GB, Radaelli A, Perlini S, Ferrari AU. Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure. Circulation 106: 866-872, 2002.
44. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Long-term heart rate reduction induced by the selective If current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109: 1674-1679, 2004.
45. Muscholl E. Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol Heart Circ Physiol 239: H713-H720, 1980.
46. Nobrega AC, Carvalho AC, Bastos BG. Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans. Braz J Med Biol Res 29: 1461-1465, 1996.
47. Nobrega AC, Dos Reis AF, Moraes RS, Bastos BG, Ferlin EL, Ribeiro JP. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin Auton Res 11: 11-17, 2001.
48. Okazaki Y, Zheng C, Li M, Sugimachi M. Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure. J Physiol Sci 60: 67-74, 2010.
49. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympa-thetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118: 863-871, 2008.
50. Opthof T. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 45: 177-184, 2000.
51. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protocol 3: 1422-1433, 2008.
52. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172, 1990.
53. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979.
54. Porter TR, Eckberg DL, Fritsch JM, Rea RF, Beightol LA, Schmedtje JF, Mohanty PK. Autonomic pathophysiology in heart failure patients: sympathetic-cholinergic interrelations. J Clin Invest 85: 1362-1371, 1990.
55. Reddy MK, Schultz HD, Zheng H, Patel KP. Altered nitric oxide mechanism within the paraventricular nucleus contributes to the augmented carotid body chemoreflex in heart failure. Am J Physiol Heart Circ Physiol 292: H149-H157, 2007.
56. Rocha-Resende C, Roy A, Resende R, Ladeira MS, Lara A, de Morais Gomes ER, Prado VF, Gros R, Guatimosim C, Prado MA, Guatimo-sim S. Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals. J Mol Cell Cardiol 53: 206-216, 2012.
57. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306, 1985.
58. Rosenblueth A, Simeone FA. The interrelations of vagal and accelerator effects on the cardiac rate. Am J Physiol 110: 42-55, 1934.
59. Sabino JP, Silva CA, Melo RF, Fazan R Jr, Salgado HC. The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure. Auton Neurosci 173: 58-64, 2013.
60. Schwartz PJ, De Ferrari GM. Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev 16: 101-107, 2011.
61. Segers VFM, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116: 1683- 1692, 2007.
62. Serra SM, Costa RV, Castro RRT, Xavier SS, Nóbrega AC. Cholin-ergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. J Card Fail 15: 124-129, 2009.
63. Soares PPS, Nóbrega ACL, Ushizima MR, Irigoyen MCC. Cholinergic stimulation with pyridostigmine increases heart rate variability and baro-reflex sensitivity in rats. Auton Neurosci 113: 24-31, 2004.
64. Soeki T, Tamura Y, Shinohara H, Tanaka H, Bando K, Fukuda N. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology 93: 168-174, 2000.
65. Stewart JT, Simpson IA, Smith RE, Callicott C, Gray HH, Camm AJ. Left ventricular energetics: heat production by the human heart. Cardio-vasc Res 27: 1024-1032, 1993.
66. Tamura K, Nakajima H, Rakue H, Sasame A, Naito Y, Nagai Y, Ibukiyama C. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. Jpn Circ J 63: 357-361, 1999.
67. Taylor P. Anticholinesterase agents. In: Goodman and Gilman's, The Pharmacological Basis of Therapeutics, edited by Hardman JG, Limbird LE, and Gilman AG. New York: McGraw-Hill, 175-192, 2001.
68. Teerlink JR, Clozel JP. Hemodynamic variability and circadian rhythm in rats with heart failure: role of the locomotor activity. Am J Physiol Heart Circ Physiol 264: H2111-H2118, 1993.
69. Todd GL, Baroldi G, Pieper GM, Clayton FC, Eliot RS. Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesion. J Mol Cell Cardiol 17: 317-338, 1985.
70. Van Den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibro-blasts. Nat Rev Cardiol 7: 30-37, 2010.
71. Vanhoutte PM, Levy MN. Prejunctional chonilergic modulation of ad-renergic neurotransmission in the cardiovascular system. Am J Physiol Heart Circ Physiol 238: H275-H281, 1980.
72. Watanabe AM, Lindemann JP, Fleming JW. Mechanisms of musca-rinic modulation of protein phosphorylation in intact ventricles. Fed Proc 43: 2618-2623, 1984.
73. Zhang Y, Popovic ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2: 692-699, 2009.
74. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ. Brady-cardia induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 85: 192-198, 1999.
75. Zucker IH, Wang W, Brandle M, Schultz HD, Patel KP. Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis 37: 397-414, 1995.